Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734979 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02734979: Completed NA study, sponsored by Stanford University.
NCT02734979 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734979, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To investigate whether addition of the Biobridge scaffold to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
Primary Outcome
Lymphoscintigraphy, a measure of limb volume indicative of adequate limb drainage, was conducted on the arm receiving BioBridge implantation (affected arm) and the contralateral (unaffected) arm, before surgery (baseline) and 1 year following surgical implantation of the Biobridge device. The outcome is reported as the median difference in the pre-implantation baseline value and the value 1 year after surgery for each arm.
Interventions
- DEVICE Biobridge and lymph node transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-07-20 |
| Est. Completion | 2020-10-29 |
| Phase | NA |
What the finished NCT02734979 record still lists
NCT02734979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Biobridge and lymph node transfer is the first listed.
NCT02734979 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02734979 about?
NCT02734979 is a clinical study titled "Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema". To investigate whether addition of the Biobridge scaffold to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
What is the current status of trial NCT02734979?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2016-07-20. Estimated completion is 2020-10-29.
What interventions are being tested in trial NCT02734979?
The interventions under investigation include: Biobridge and lymph node transfer (DEVICE).
Who is sponsoring clinical trial NCT02734979?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02734979's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI